Skip to main content

Peer Review reports

From: A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances

Original Submission
17 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Mar 2022 Reviewed Reviewer Report - Steven Silverstein
15 Jul 2022 Reviewed Reviewer Report - Helena M. Van Minderhout
15 Aug 2022 Author responded Author comments - Kavon Rahmani
Resubmission - Version 4
15 Aug 2022 Submitted Manuscript version 4
23 Aug 2022 Author responded Author comments - Kavon Rahmani
Resubmission - Version 5
23 Aug 2022 Submitted Manuscript version 5
28 Aug 2022 Author responded Author comments - Kavon Rahmani
Resubmission - Version 6
28 Aug 2022 Submitted Manuscript version 6
29 Aug 2022 Author responded Author comments - Kavon Rahmani
Resubmission - Version 7
29 Aug 2022 Submitted Manuscript version 7
5 Sep 2022 Reviewed Reviewer Report - Helena M. Van Minderhout
16 Sep 2022 Reviewed Reviewer Report - Steven Silverstein
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
26 Sep 2022 Editorially accepted
8 Oct 2022 Article published 10.1186/s12886-022-02621-6

You can find further information about peer review here.

Back to article page